TY  - JOUR 
AU  - Montero González, Juan Carlos
AU  - Calvo Jiménez, Elisa
AU  - Carmen Martínez, Sofía del
AU  - Abad Hernández, María Mar
AU  - Ocaña, Alberto
AU  - Pandiella Alonso, Atanasio
PY  - 2022
UR  - http://hdl.handle.net/10366/168827
AB  - [EN]Background: Despite the incorporation of novel therapeutics, advanced triple negative breast cancer (TNBC) still
represents a relevant clinical problem. Considering this, as well as the clinical efficacy of antibody-drug conjugates
(ADCs), we...
LA  - eng
PB  - BioMed Central
KW  - CD98hc
KW  - Antibody-drug conjugates
KW  - Triple negative breast cancer
KW  - Targeted therapy
KW  - Pathology
TI  - Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer
DO  - 10.1186/S13046-022-02330-4
T2  - Journal of Experimental & Clinical Cancer Research
VL  - 41
ER  -